Pestpodden

Ebola er et høyaktuelt tema i disse dager med det pågående utbruddet i DR Kongo. For å gi litt mer bakgrunn gjør vi en historisk reise fra oppdagelsen av Ebola frem til i dag. Referanser:https://www.gov.uk/government/publications/ebola-overview-history-origins-and-transmission/ebola-overview-history-origins-and-transmission https://time.com/3548047/first-ebola-outbreak-history/ https://en.wikipedia.org/wiki/Kivu_Ebola_epidemichttps://en.wikipedia.org/wiki/Western_African_Ebola_epidemichttps://en.wikipedia.org/wiki/Ebolahttps://www.who.int/news-room/fact-sheets/detail/ebola-diseasehttps://journals.physiology.org/doi/full/10.1152/ajplung.00354.2014 https://www.sciencedirect.com/science/article/pii/S1286457905001437

Ingrid, Jørgen og Nikolai oppsummerer etter beste evne årets ESCMID (en av verdens største infeksjonsmedisinske konferanser) og vårmøtet (kanskje en av verdens minste infeksjonskonferanser) i denne reporasje-baserte episoden av Pestpodden.Referanser:1.    White NM, et al. Effectiveness of oral care for the prevention of non-ventilator hospital-acquired pneumonia (HAPPEN): a multicentre, stepped-wedge, cluster-randomised trial in Australia. Lancet Infect Dis. 2026.2.    Israelsen SB, et al. Short-course antibiotic therapy of 5 days in community-acquired pneumonia (CAP5): study protocol for a randomised controlled trial. BMJ Open. 2023;13:e069013. doi: 10.1136/bmjopen-2022-069013.  3.    Chanderraj R, et al. Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime. JAMA Intern Med. 2024;184(7):769-77.4.    Azevedo LCP, et al. Using the 2026 Surviving Sepsis Campaign Guidelines in Practice. Crit Care Sci. 2026;38:e20260036.5.    Doumat G, et al. Short Versus Longer Antibiotic Duration for Community-Acquired Pneumonia : A Multicenter Target Trial Emulation. Ann Intern Med. 2026;179(5):629-36.6.    Overdevest AG, et al. Antibiotic treatment for 1 day versus 4–7 days in patients with acute cholangitis after adequate endoscopic biliary drainage (COBRA): study protocol for a randomized controlled trial. Trials. 2026. doi: 10.1186/s13063-026-09524-7. PubMed: PMID 41689066. 7.    Turner NA, et al. Dalbavancin for Treatment of Staphylococcus aureus Bacteremia: The DOTS Randomized Clinical Trial. JAMA. 2025.8.    Kristensen LH, et al. Diagnostic accuracy of dipsticks for urinary tract infections in acutely hospitalised patients: a prospective population-based observational cohort study. BMJ Evid Based Med. 2025;30(1):36-44.9.    Giamarellos-Bourboulis EJ, et al. Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial. JAMA. 2026;335(9):775-86.

We take an in-depth look at cryptococcal disease with dr Neil Stone - hold tight and dive with us! This episode will go though everything from epidemiologi and risk-factors - to typical clinical pictures and treatment.

Jørgen og Ingrid har vært på ekspedisjon til NSCMID 2025 - og sydd sammen et sammendrag fra denne årlige, nordiske konferansen. Gjør deg klar for litt av høstens infeksjonsmedisinske nyheter - og litt hobbyentymologiske betrakninger rundt mygg kommer gratis med på kjøpet!

In today`s episode we speaking with Neil Stone, consultant in ID and microbiology, lead for mycology at University College Hospital London/Hospital for Tropical Diseases associate professor at University College London. We give you a "broad-spectrum"-dive into the fungus-field, including the latest news on Candida auris, strange names of new drugs and the other mysteries of mycology.

Høsten er her og det samme er soppen! Vi har intervjuet mykolog, biolog og professor Klaus Høiland om alle soppens fortreffeligheter - fra tidenes morgen til i dag. Bli med på en fun(gus)fact-spekket episode!